Relypsa
Galenica announces $1.53 billion Replysa acquisition
July 21, 2016Research and Development, Sales and Marketing Relypsa, Vifor pharma, galenica
Galenica has announced that it has entered into an agreement to acquire Relypsa in a deal worth $1.53 billion, which …
Weekly Movers: Valeant, Depomed, Intercept Pharma, Insys Therapeutics and more…
April 18, 2016Manufacturing and Production, Research and Development, Sales and Marketing Depomed, Intercept Pharma, Relypsa, Share price, Stock Movement, Valeant, stock market
Troubles don’t seem to go away for Canada-based Valeant Pharma (NYSE: VRX) with news of a probable sale doing the …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
